Broad-spectrum neutralization of pore-forming toxins with human erythrocyte membrane-coated nanosponges

Summary

This antivirulence study develops a structure-independent method for neutralizing pore-forming bacterial toxins. Instead of identifying each toxin and designing a matching inhibitor, the researchers coated polymeric nanoparticle cores with human red-blood-cell membrane. The resulting nanosponges mimic a natural target of hemolytic toxins, causing diverse molecules to insert into the decoy membrane rather than damage living cells. Testing included melittin, MRSA alpha-hemolysin, Listeria listeriolysin O, and Group A Streptococcus streptolysin O. Across these examples, the particles completely blocked toxin-induced hemolysis in a concentration-dependent manner. Toxins detained by the nanosponges were not cytotoxic to human umbilical-vein endothelial cells and caused no lethality when injected into mice, supporting functional neutralization rather than temporary binding alone. The principal finding is broad activity across molecularly distinct pore-forming toxins through their shared membrane-directed mechanism. Its significance is a potentially resistance-sparing platform that could be deployed without a custom antidote for every bacterial strain or toxin. The abstract does not test live infections, define dosing or clearance, compare existing antitoxins, address saturation and toxin release, or establish clinical safety.